Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Lgi2 | Rat | 1,1-dichloroethene | increases expression | ISO | Lgi2 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of LGI2 mRNA | CTD | PMID:26682919 | Lgi2 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Lgi2 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of LGI2 mRNA | CTD | PMID:22206623 | Lgi2 | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of LGI2 mRNA | CTD | PMID:30723492 | Lgi2 | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LGI2 mRNA | CTD | PMID:32741896 | Lgi2 | Rat | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LGI2 mRNA | CTD | PMID:32741896 | Lgi2 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of LGI2 mRNA | CTD | PMID:21394737 | Lgi2 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Lgi2 (Mus musculus) | 6480464 | 2,2',4,4',5-brominated diphenyl ether affects the expression of LGI2 mRNA | CTD | PMID:38648751 | Lgi2 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Lgi2 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of LGI2 mRNA | CTD | PMID:28973697 | Lgi2 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of LGI2 mRNA | CTD | PMID:28959563 | Lgi2 | Rat | aflatoxin B1 | increases methylation | ISO | LGI2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of LGI2 exon | CTD | PMID:30157460 | Lgi2 | Rat | aflatoxin B1 | decreases methylation | ISO | LGI2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of LGI2 intron | CTD | PMID:30157460 | Lgi2 | Rat | alpha-Zearalanol | decreases expression | EXP | | 6480464 | Zeranol results in decreased expression of LGI2 mRNA | CTD | PMID:35163327 | Lgi2 | Rat | benzo[a]pyrene | increases expression | ISO | Lgi2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of LGI2 mRNA | CTD | PMID:22228805 | Lgi2 | Rat | benzo[a]pyrene | affects methylation | ISO | LGI2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of LGI2 exon; Benzo(a)pyrene affects the methylation of LGI2 intron; Benzo(a)pyrene more ... | CTD | PMID:27901495|PMID:30157460 | Lgi2 | Rat | benzo[a]pyrene | increases methylation | ISO | LGI2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of LGI2 3' UTR | CTD | PMID:27901495 | Lgi2 | Rat | benzo[b]fluoranthene | increases expression | ISO | Lgi2 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of LGI2 mRNA | CTD | PMID:26377693 | Lgi2 | Rat | benzo[e]pyrene | decreases methylation | ISO | LGI2 (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of LGI2 intron | CTD | PMID:30157460 | Lgi2 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of LGI2 mRNA | CTD | PMID:25181051 | Lgi2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of LGI2 mRNA | CTD | PMID:30816183|PMID:32528016|PMID:34947998|PMID:36779543 | Lgi2 | Rat | bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of LGI2 mRNA | CTD | PMID:32479839 | Lgi2 | Rat | cadmium dichloride | increases expression | ISO | LGI2 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of LGI2 mRNA | CTD | PMID:38568856 | Lgi2 | Rat | cantharidin | increases expression | ISO | Lgi2 (Mus musculus) | 6480464 | Cantharidin results in increased expression of LGI2 mRNA | CTD | PMID:36907384 | Lgi2 | Rat | carbon nanotube | increases expression | ISO | Lgi2 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of LGI2 mRNA; Nanotubes, Carbon results in increased more ... | CTD | PMID:25554681 | Lgi2 | Rat | CGP 52608 | multiple interactions | ISO | LGI2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to LGI2 gene] | CTD | PMID:28238834 | Lgi2 | Rat | choline | multiple interactions | ISO | Lgi2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Lgi2 | Rat | DDT | decreases methylation | EXP | | 6480464 | DDT results in decreased methylation of LGI2 gene | CTD | PMID:30207508 | Lgi2 | Rat | dibenz[a,h]anthracene | increases expression | ISO | Lgi2 (Mus musculus) | 6480464 | 1,2,5,6-dibenzanthracene results in increased expression of LGI2 mRNA | CTD | PMID:26377693 | Lgi2 | Rat | dimethylarsinic acid | increases methylation | EXP | | 6480464 | Cacodylic Acid results in increased methylation of LGI2 gene | CTD | PMID:37958445 | Lgi2 | Rat | diquat | increases expression | ISO | Lgi2 (Mus musculus) | 6480464 | Diquat results in increased expression of LGI2 mRNA | CTD | PMID:36851058 | Lgi2 | Rat | doxorubicin | decreases expression | ISO | LGI2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of LGI2 mRNA | CTD | PMID:29803840 | Lgi2 | Rat | ethanol | affects splicing | ISO | Lgi2 (Mus musculus) | 6480464 | Ethanol affects the splicing of LGI2 mRNA | CTD | PMID:30319688 | Lgi2 | Rat | folic acid | multiple interactions | ISO | Lgi2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Lgi2 | Rat | folic acid | increases expression | ISO | LGI2 (Homo sapiens) | 6480464 | Folic Acid results in increased expression of LGI2 mRNA | CTD | PMID:21867686 | Lgi2 | Rat | fulvestrant | decreases methylation | ISO | LGI2 (Homo sapiens) | 6480464 | Fulvestrant results in decreased methylation of LGI2 gene | CTD | PMID:31601247 | Lgi2 | Rat | genistein | increases expression | ISO | Lgi2 (Mus musculus) | 6480464 | Genistein results in increased expression of LGI2 mRNA | CTD | PMID:32186404 | Lgi2 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of LGI2 mRNA | CTD | PMID:33387578 | Lgi2 | Rat | GW 4064 | decreases expression | ISO | Lgi2 (Mus musculus) | 6480464 | GW 4064 results in decreased expression of LGI2 mRNA | CTD | PMID:26655953 | Lgi2 | Rat | L-methionine | multiple interactions | ISO | Lgi2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Lgi2 | Rat | lipopolysaccharide | decreases expression | ISO | LGI2 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of LGI2 mRNA | CTD | PMID:35811015 | Lgi2 | Rat | lipopolysaccharide | multiple interactions | ISO | LGI2 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LGI2 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Lgi2 | Rat | methapyrilene | decreases methylation | ISO | LGI2 (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of LGI2 intron | CTD | PMID:30157460 | Lgi2 | Rat | Moniliformin | decreases expression | ISO | Lgi2 (Mus musculus) | 6480464 | moniliformin results in decreased expression of LGI2 mRNA | CTD | PMID:39984025 | Lgi2 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of LGI2 mRNA | CTD | PMID:33387578 | Lgi2 | Rat | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of LGI2 mRNA | CTD | PMID:32680482 | Lgi2 | Rat | potassium dichromate | increases expression | ISO | Lgi2 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of LGI2 mRNA | CTD | PMID:23608068 | Lgi2 | Rat | pravastatin | increases expression | EXP | | 6480464 | Pravastatin results in increased expression of LGI2 mRNA | CTD | PMID:27225895 | Lgi2 | Rat | pravastatin | increases expression | ISO | Lgi2 (Mus musculus) | 6480464 | Pravastatin results in increased expression of LGI2 mRNA | CTD | PMID:27225895 | Lgi2 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | LGI2 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LGI2 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Lgi2 | Rat | silicon dioxide | increases expression | ISO | Lgi2 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of LGI2 mRNA | CTD | PMID:29341224 | Lgi2 | Rat | sunitinib | decreases expression | ISO | LGI2 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of LGI2 mRNA | CTD | PMID:31533062 | Lgi2 | Rat | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LGI2 mRNA | CTD | PMID:32741896 | Lgi2 | Rat | titanium dioxide | increases expression | ISO | Lgi2 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of LGI2 mRNA | CTD | PMID:21259345|PMID:27760801 | Lgi2 | Rat | titanium dioxide | increases methylation | ISO | Lgi2 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of LGI2 gene | CTD | PMID:35295148 | Lgi2 | Rat | titanium dioxide | affects expression | ISO | Lgi2 (Mus musculus) | 6480464 | titanium dioxide affects the expression of LGI2 mRNA | CTD | PMID:23557971 | Lgi2 | Rat | triclosan | decreases expression | ISO | LGI2 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of LGI2 mRNA | CTD | PMID:30510588 | Lgi2 | Rat | trimellitic anhydride | decreases expression | ISO | Lgi2 (Mus musculus) | 6480464 | trimellitic anhydride results in decreased expression of LGI2 mRNA | CTD | PMID:19042947 | Lgi2 | Rat | zaragozic acid A | affects expression | ISO | Lgi2 (Mus musculus) | 6480464 | squalestatin 1 affects the expression of LGI2 mRNA | CTD | PMID:27225895 | Lgi2 | Rat | zaragozic acid A | decreases expression | EXP | | 6480464 | squalestatin 1 results in decreased expression of LGI2 mRNA | CTD | PMID:27225895 | Lgi2 | Rat | zoledronic acid | decreases expression | ISO | LGI2 (Homo sapiens) | 6480464 | zoledronic acid results in decreased expression of LGI2 mRNA | CTD | PMID:24714768 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















